GO:0098838 folate transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098838 (folate transmembrane transport) describes the movement of folic acid and its reduced derivatives (dihydrofolate, tetrahydrofolate, methylene-tetrahydrofolate, methyl-tetrahydrofolate) across biological membranes.
• The reduced folate carrier (RFC/SLC19A1) is the major bidirectional transporter for reduced folates and antifolates in mammalian cells.
• Transport can be driven by a transmembrane pH gradient via folate/hydroxyl exchange, as shown in rabbit jejunum brush border membrane vesicles.
• RFC-mediated transport can operate through an antiport mechanism, coupling folate uptake to efflux of intracellular anions such as 5-aminoimidazole-4-carboxamide riboside monophosphate.
• Mutations clustered in the first transmembrane domain of human RFC impair antifolate transport and can augment folate uptake, linking structure to substrate selectivity.
• Folate transport is not limited to mammals; Toxoplasma gondii can import exogenous folate via a BT1-family transmembrane protein, highlighting evolutionary diversity.
Description
Folate transmembrane transport (GO:0098838) is the biological process by which folic acid or one of its derivatives, including dihydrofolate, tetrahydrofolate, methylene-tetrahydrofolate and methyl-tetrahydrofolate, is moved across a membrane. Because folates are hydrophilic and cannot diffuse freely through lipid bilayers, cells depend on dedicated transport proteins to supply one-carbon units for nucleotide synthesis, amino acid metabolism and methylation reactions. The process is therefore central to cell proliferation and is a long-standing target in cancer chemotherapy and antifolate drug design. Mechanistic studies have defined multiple transport modes. The reduced folate carrier (RFC, SLC19A1) mediates bidirectional, high-affinity transport of reduced folates and antifolates. In intestinal brush border membranes, folate uptake is driven by a transmembrane pH gradient through a folate/hydroxyl exchange mechanism. RFC activity can also be augmented by an antiport mechanism in which intracellular 5-aminoimidazole-4-carboxamide riboside monophosphate is exchanged for extracellular folate/antifolate substrates. Structural work using co-expressed RFC half-molecules localized a substrate-binding domain to transmembrane domains 7-12, while mutations in the first transmembrane domain alter substrate specificity. Beyond mammals, exogenous folate transport occurs in protozoan parasites such as Toxoplasma gondii through a BT1-family transmembrane protein, indicating that folate transport is an ancient and functionally diverse process. Understanding GO:0098838 thus connects membrane biology, pharmacology and metabolic disease research.
folate transmembrane transport At A Glance
| GO ID | GO:0098838 |
|---|---|
| GO term | folate transmembrane transport |
| Ontology | biological_process |
| Synonym | folic acid transmembrane transport; reduced folate transmembrane transport |
| Major function | Movement of folic acid and reduced folate derivatives across biological membranes |
| Representative substrates | Folic acid, dihydrofolate, tetrahydrofolate, methylene-tetrahydrofolate, methyl-tetrahydrofolate |
| Key transporter | Reduced folate carrier (RFC/SLC19A1) |
| Transport modes | Bidirectional carrier-mediated transport; pH-gradient-driven folate/hydroxyl exchange; antiport with intracellular anions |
| Disease relevance | Antifolate resistance in leukemia; folate-related metabolic and proliferative disorders |
What Is GO:0098838?
GO:0098838 (folate transmembrane transport) is defined as the process in which a folic acid molecule, or one of its derivatives such as dihydrofolate, tetrahydrofolate, methylene-tetrahydrofolate or methyl-tetrahydrofolate, is transported across a membrane. It is a biological_process term whose synonyms include folic acid transmembrane transport and reduced folate transmembrane transport. The term covers the directed movement of these substrates from one side of a membrane to the other, whether mediated by carrier proteins, exchangers or other transport systems.
Why Is folate transmembrane transport Important in Cell Biology?
Folate transmembrane transport is essential because it controls the intracellular supply of one-carbon donors required for DNA synthesis, amino acid metabolism and methylation. The reduced folate carrier is the principal route for reduced folate and antifolate entry into mammalian cells, making this process a determinant of chemotherapy response and resistance. Mutations in RFC transmembrane domains can selectively impair antifolate transport while augmenting folate uptake, directly linking transport structure to drug sensitivity. In intestinal epithelium, pH-gradient-driven folate/hydroxyl exchange provides a mechanism for uphill folate absorption, and antiport activity can further modulate intracellular folate/antifolate balance. The existence of BT1-family folate transporters in Toxoplasma gondii shows that this process is also relevant to infectious disease and parasite metabolism.
• Supplies reduced folates needed for nucleotide biosynthesis and cell proliferation.
• Determines cellular uptake of antifolate drugs such as methotrexate and related compounds.
• Mutations in RFC transmembrane domains can cause antifolate resistance in leukemia cells.
• pH-gradient-driven folate/hydroxyl exchange enables uphill folate absorption in the intestine.
• Antiport with intracellular anions can augment RFC-mediated folate/antifolate transport.
• Substrate binding domains in RFC transmembrane domains 7-12 define transport specificity.
• BT1-family transporters mediate exogenous folate uptake in Toxoplasma gondii.
• Folate transport is a potential target for antiparasitic and anticancer strategies.
• Altered folate transport can influence one-carbon metabolism and methylation capacity.
• Transport assays in membrane vesicles provide direct evidence for exchange mechanisms.
What Happens During folate transmembrane transport?
Substrate recognition at the membrane
In simple terms: The transporter first recognizes and binds folate or a related molecule at the cell membrane.
Folate transmembrane transport begins with substrate recognition by a membrane transporter. The reduced folate carrier binds reduced folates and antifolates with high affinity, and substrate binding domains have been localized to transmembrane domains 7-12 using co-expressed RFC half-molecules in transport-impaired K562 cells. Mutations clustered in the first transmembrane domain of human RFC alter substrate specificity, impairing antifolate transport while augmenting folate uptake in GW1843U89-resistant leukemia cells. These findings show that distinct transmembrane regions contribute to substrate recognition and selectivity.
Translocation across the lipid bilayer
In simple terms: Once bound, the folate molecule is moved through the membrane to the other side.
After substrate binding, the transporter undergoes conformational changes that translocate the folate molecule across the lipid bilayer. RFC mediates bidirectional transport of reduced folates and antifolates, allowing movement down or against concentration gradients depending on cellular conditions. In rabbit jejunum brush border membrane vesicles, a transmembrane pH gradient drives uphill folate transport, providing direct evidence for folate/hydroxyl exchange as a translocation mechanism. This exchange mode couples folate movement to the counter-transport of hydroxyl ions.
Antiport and exchange mechanisms
In simple terms: Some transporters swap one molecule for another across the membrane.
Folate transport can occur through antiport mechanisms. RFC-mediated folate/antifolate transport is augmented by an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate, in which intracellular anion efflux is coupled to folate uptake. This antiport activity modulates the intracellular balance of folates and antifolates and can influence drug sensitivity. The pH-gradient-driven folate/hydroxyl exchange in intestinal brush border membranes represents another exchange mode for uphill folate absorption.
Diversity of folate transport systems
In simple terms: Different organisms use different proteins to transport folate.
Folate transmembrane transport is not restricted to the mammalian reduced folate carrier. Toxoplasma gondii is capable of exogenous folate transport through a BT1-family transmembrane protein, suggesting an expansion of this family for folate uptake in protozoan parasites. This evolutionary diversity indicates that multiple protein families can mediate GO:0098838, and that transport mechanisms may differ between organisms. Comparative studies of these systems can inform antiparasitic and anticancer drug development.
Key Genes Involved in GO:0098838 folate transmembrane transport
The following genes and proteins have been experimentally implicated in folate transmembrane transport or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC19A1 (RFC) | Major bidirectional transporter for reduced folates and antifolates | Central to antifolate sensitivity and resistance studies |
| SLC19A1 transmembrane domain 1 | Contains mutations that impair antifolate transport and augment folate uptake | Model for substrate specificity and drug resistance |
| SLC19A1 transmembrane domains 7-12 | Localize a substrate binding domain | Structural mapping of transport function |
| BT1-family transporter (T. gondii) | Mediates exogenous folate transport in Toxoplasma gondii | Parasite folate uptake and antiparasitic targeting |
| Folate/hydroxyl exchanger (jejunal brush border) | Drives uphill folate transport via transmembrane pH gradient | Intestinal folate absorption mechanism |
| RFC antiport system | Couples folate/antifolate transport to AICAR monophosphate efflux | Modulation of intracellular folate/antifolate balance |
| Folic acid | Substrate for folate transmembrane transport | Baseline substrate for transport assays |
| Dihydrofolate | Reduced folate derivative transported across membranes | Substrate for RFC-mediated transport |
| Tetrahydrofolate | Reduced folate derivative transported across membranes | One-carbon metabolism substrate |
| Methylene-tetrahydrofolate | Reduced folate derivative transported across membranes | Nucleotide synthesis substrate |
| Methyl-tetrahydrofolate | Reduced folate derivative transported across membranes | Methylation cycle substrate |
| GW1843U89 | Antifolate used to select resistant leukemia cells | Tool for studying RFC mutations |
| AICAR monophosphate | Intracellular anion that participates in antiport | Regulates RFC-mediated transport |
| K562 cells | Transport-impaired cell line used for RFC half-molecule studies | Complementation and localization experiments |
| Rabbit jejunum brush border membrane vesicles | Model for pH-gradient-driven folate transport | Direct evidence for folate/hydroxyl exchange |
How Is folate transmembrane transport Regulated?
Folate transmembrane transport is regulated at multiple levels. The reduced folate carrier mediates bidirectional transport, so the direction and rate of flux depend on substrate gradients and cellular metabolic state. A transmembrane pH gradient can drive uphill folate transport through folate/hydroxyl exchange in intestinal brush border membranes. In addition, RFC-mediated transport can be augmented by an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate, linking transport activity to intracellular anion levels. Mutations in RFC transmembrane domains can alter substrate specificity and transport capacity, providing a genetic layer of regulation.
folate transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC19A1 (RFC) | Antifolate resistance in leukemia | GW1843U89-resistant leukemia cell lines with RFC mutations |
| SLC19A1 transmembrane domain 1 | Impaired antifolate transport, augmented folate uptake | Site-directed mutagenesis and transport assays |
| BT1-family transporter (T. gondii) | Parasite folate uptake | Toxoplasma gondii folate transport assays |
| Folate/hydroxyl exchanger | Intestinal folate absorption | Rabbit jejunum brush border membrane vesicles |
| RFC antiport system | Intracellular folate/antifolate balance | AICAR monophosphate antiport assays |
Antifolate resistance in leukemia
Mutations clustered in the first transmembrane domain of the human reduced folate carrier were identified in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake. This demonstrates that altered folate transmembrane transport can directly cause resistance to antifolate chemotherapy. RFC is the major transporter for reduced folates and antifolates, so changes in its function affect drug efficacy.
Intestinal folate absorption disorders
In rabbit jejunum brush border membrane vesicles, a transmembrane pH gradient drives uphill folate transport via folate/hydroxyl exchange. This mechanism is relevant to understanding intestinal folate absorption and may inform research on folate deficiency and malabsorption. The exchange model provides direct evidence for how the intestinal epithelium concentrates folate from the lumen.
Parasitic infections
Toxoplasma gondii is capable of exogenous folate transport through a BT1-family transmembrane protein, suggesting that folate uptake is important for parasite survival. This raises the possibility that folate transport pathways could be explored as targets for antiparasitic intervention. The expansion of the BT1 family in protozoa highlights evolutionary adaptations in folate transmembrane transport.
From folate transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RFC abolish reduced folate transport? | SLC19A1 knockout cell lines |
| Do specific RFC transmembrane mutations alter substrate specificity? | Point-mutation knock-in of SLC19A1 variants |
| Can a tagged RFC be used to track localization? | Tagged knock-in of SLC19A1 |
| Does overexpression of RFC increase antifolate sensitivity? | SLC19A1 overexpression cell models |
| Is a BT1-family transporter sufficient for folate uptake? | Heterologous expression in transport-impaired cells |
| Does pH gradient drive folate transport? | Brush border membrane vesicle assays |
How to Study the folate transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Membrane vesicle transport assay | Folate flux across membranes | pH-gradient-driven folate/hydroxyl exchange |
| Site-directed mutagenesis | Effect of specific residues on transport | Mapping RFC transmembrane domain function |
| Complementation in transport-impaired cells | Restoration of transport activity | RFC half-molecule assembly and domain localization |
| Antiport assay | Coupling of folate transport to anion efflux | AICAR monophosphate antiport with RFC |
| Heterologous expression | Folate uptake by candidate transporters | BT1-family transporter studies in T. gondii |
| Substrate competition assay | Specificity for folates vs antifolates | RFC substrate selectivity |
| Cell proliferation assay | Antifolate sensitivity | RFC mutation and resistance studies |
| Radiolabeled folate uptake | Kinetics of folate transport | Bidirectional transport characterization |
Transport assays in membrane vesicles
Membrane vesicle assays provide direct measurements of folate transport. Rabbit jejunum brush border membrane vesicles were used to demonstrate that a transmembrane pH gradient drives uphill folate transport via folate/hydroxyl exchange. Such assays can define substrate specificity, directionality and exchange mechanisms for GO:0098838.
Mutagenesis and complementation
Site-directed mutagenesis and complementation in transport-impaired cells can map functional domains. Co-expression of human reduced folate carrier half-molecules in transport-impaired K562 cells restored transport activity and localized a substrate binding domain to transmembrane domains 7-12. Mutations in the first transmembrane domain were linked to altered antifolate transport and augmented folate uptake.
Antiport and exchange measurements
Antiport assays can reveal coupling between folate transport and intracellular anions. RFC-mediated folate/antifolate transport is augmented by an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate. Measuring intracellular anion levels alongside transport rates helps define exchange stoichiometry and regulation.
Comparative and parasite transport studies
Comparative studies across species can identify diverse folate transport systems. Toxoplasma gondii folate transport via a BT1-family transmembrane protein demonstrates that exogenous folate uptake occurs in protozoa. Heterologous expression and transport assays can test whether candidate transporters mediate GO:0098838.
How CRISPR Can Be Used to Study GO:0098838 folate transmembrane transport
Knockout
CRISPR knockout of SLC19A1 (RFC) can eliminate reduced folate transport and create a clean background for testing whether candidate genes mediate GO:0098838. Such models are useful for measuring baseline folate uptake and antifolate sensitivity.
Point Mutation
Point-mutation knock-in can reproduce specific RFC transmembrane domain mutations identified in antifolate-resistant leukemia cells, such as those in the first transmembrane domain that impair antifolate transport and augment folate uptake. These models allow precise structure-function analysis of folate transport.
Knock-in
Tagged knock-in of SLC19A1 can enable localization and interaction studies of the reduced folate carrier in its native context. This complements domain-mapping studies that localized a substrate binding domain to transmembrane domains 7-12.
Overexpression
Overexpression of RFC or candidate BT1-family transporters can test whether increased protein levels enhance folate transport and alter antifolate sensitivity. Overexpression models are also useful for antiport studies involving intracellular anions such as AICAR monophosphate.
How EDITGENE Supports folate transmembrane transport Research
Researchers studying folate transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in folate uptake, antifolate response or membrane exchange. EDITGENE provides CRISPR-based cell model services that enable precise manipulation of SLC19A1, BT1-family transporters and related genes, supporting functional studies of GO:0098838.
Contact EDITGENE today to design your custom CRISPR model for folate transmembrane transport research.
Frequently Asked Questions About folate transmembrane transport
What is folate transmembrane transport?
Folate transmembrane transport (GO:0098838) is the process in which folic acid or one of its derivatives, such as dihydrofolate, tetrahydrofolate, methylene-tetrahydrofolate or methyl-tetrahydrofolate, is transported across a membrane.
What genes are involved in folate transmembrane transport?
The reduced folate carrier (SLC19A1/RFC) is the major transporter for reduced folates and antifolates, and BT1-family transporters mediate folate uptake in Toxoplasma gondii.
How does the reduced folate carrier transport folate?
RFC mediates bidirectional transport of reduced folates and antifolates, and its activity can be augmented by an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate.
What drives uphill folate transport in the intestine?
A transmembrane pH gradient drives uphill folate transport in rabbit jejunum brush border membrane vesicles via folate/hydroxyl exchange.
Which RFC domains bind folate substrates?
A substrate binding domain has been localized to transmembrane domains 7-12 using co-expressed human RFC half-molecules in transport-impaired K562 cells.
How do RFC mutations affect antifolate resistance?
Mutations clustered in the first transmembrane domain of human RFC impair antifolate transport and augment folate uptake in GW1843U89-resistant leukemia cells.
Is folate transport found in parasites?
Yes, Toxoplasma gondii can transport exogenous folate via a BT1-family transmembrane protein.
What is the difference between folate transmembrane transport and folate metabolism?
Folate transmembrane transport (GO:0098838) specifically covers movement of folates across membranes, whereas folate metabolism refers to intracellular enzymatic conversions.
How can I study folate transmembrane transport in the lab?
Common approaches include membrane vesicle transport assays, site-directed mutagenesis, complementation in transport-impaired cells and antiport measurements.
Why is folate transmembrane transport important for cancer treatment?
Because RFC mediates antifolate drug uptake, changes in folate transport can alter chemotherapy response and resistance.
Conclusion
GO:0098838 (folate transmembrane transport) is a defined biological process covering the movement of folic acid and its reduced derivatives across membranes. Experimental evidence has established the reduced folate carrier as a central transporter, defined pH-gradient-driven folate/hydroxyl exchange in the intestine, and revealed antiport mechanisms that modulate folate and antifolate flux. Structural and mutational studies have mapped substrate binding domains and linked specific RFC mutations to antifolate resistance. Comparative work in Toxoplasma gondii shows that folate transport is evolutionarily diverse and relevant to parasitic disease. Together, these findings make folate transmembrane transport a key area for cancer pharmacology, metabolic research and infectious disease studies.
References
- 2. Matherly LH et al.. 2003. Membrane transport of folates.. Vitam Horm 66:403-56 PMID: 12852262
- 3. Drori S et al.. 2000. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.. J Biol Chem 275(40):30855-63 PMID: 10899164
- 4. Massimine KM et al.. 2005. Toxoplasma gondii is capable of exogenous folate transport. A likely expansion of the BT1 family of transmembrane proteins.. Mol Biochem Parasitol 144(1):44-54 PMID: 16159678
- 5. Schron CM et al.. 1985. The transmembrane pH gradient drives uphill folate transport in rabbit jejunum. Direct evidence for folate/hydroxyl exchange in brush border membrane vesicles.. J Clin Invest 76(5):2030-3 PMID: 4056063
- 6. Visentin M et al.. 2012. Augmentation of reduced folate carrier-mediated folate/antifolate transport through an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate.. Mol Pharmacol 82(2):209-16 PMID: 22554803
- 7. Witt TL et al.. 2004. Restoration of transport activity by co-expression of human reduced folate carrier half-molecules in transport-impaired K562 cells: localization of a substrate binding domain to transmembrane domains 7-12.. J Biol Chem 279(45):46755-63 PMID: 15337749
